NewsBenzingaWaters Says BD OneFlow LST Test And BD OneFlow B-CLPD T1 Test Receives FDA 510(k) Clearance For Identifying B-Cell Non-Hodgkin Lymphoma Waters Says BD OneFlow LST Test And BD OneFlow B-CLPD T1 Test Receives FDA 510(k) Clearance For Identifying B-Cell Non-Hodgkin Lymphoma Benzinga 2026.11.10 13:09 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84 As decision model use skyrockets, is customization is the next frontier?